Home | Privacy | Contact    

Health Information About Ovarian Cancer


Ovarian cancer - Wikipedia, the free encyclopedia
http://en.wikipedia.org/wiki/Ovarian_cancer Ovarian cancer is a cancerous growth arising from the ovary. Symptoms are frequently very subtle early on and may include: bloating, pelvic pain, difficulty eating ... more...
Ovarian Cancer Symptoms, Signs, Prognosis, Stages, Treatment ...
http://www.medicinenet.com/ovarian_cancer/article.htm Get information on ovarian cancer symptoms, signs, prognosis, staging, treatment, diagnosis, screening tests, research, and risk factors. Treatment options include ... more...
National Ovarian Cancer Coalition (NOCC) | Your National and Local ...
http://ovarian.org/ Our mission is to raise awareness of ovarian cancer and provide information on symptoms, diagnosis, treatment and support through national programs and local chapter ... more...
Ovarian Cancer Home Page - National Cancer Institute
http://www.cancer.gov/cancertopics/types/ovarian/ Information about ovarian cancer treatment, prevention, genetics, causes, screening, clinical trials, research and statistics from the National Cancer Institute. more...
Ovarian Cancer Center: Symptoms, Treatments, Prognosis, Stages ...
http://www.webmd.com/ovarian-cancer/default.htm Ovarian cancer is diagnosed in an estimated 20,000 women in the U.S. each year. Find in-depth ovarian cancer information here including its diagnosis, symptoms, and ... more...



Ovarian Cancer News


ovarian cancer - Bing News
IMPORTANT: Bing News RSS feed has moved!
Go to the new RSS page and renew your subscription.
read more...
Professor writes about painful effects of
After learning she had advanced read more...
RedCannon Security, Inc. and
FREMONT, Calif. and NEW YORK, May 9, 2012 /PRNewswire-iReach/-- RedCannon Security, Inc. announced today  that together with   read more...
Rexahn Pharmaceuticals Submits Archexin Phase II Protocol for
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase II protocol for the ... read more...

read more...